Araceli Biosciences launches Endeavor high content analysis platform

Araceli Biosciences, a provider of advanced biological imaging platforms, today announced the launch of its flagship product, the Araceli EndeavorTM. Endeavor revolutionizes drug discovery by delivering high speed, high resolution, full well scanning of cell-based assays.

Written byAraceli Biosciences
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Endeavor images 10 times the biology in a fraction of the time, acquiring every cell, every time. Endeavor combines exceptionally fast, full well imaging with sub-half micron pixel resolution, generating high quality, high resolution data.

With no training required, the Araceli platform makes high content analysis comprehensive, fast and easy. With intelligent tools users can generate quality results quickly and confidently, reducing the time needed for drug discovery. A single Endeavor system can acquire over 20,000 complete wells per day, at a market leading rate of 480 megapixels/second.

“The role of high content analysis in drug discovery has unfortunately been limited in the last 20 years due to throughput,” says Jeff Harris, General Manager of Araceli Biosciences. “It just hasn’t been fast enough. We set out to change that.”

“We are very excited to release Endeavor and address a tremendous need in the drug discovery space,” says Maggie Vantangoli Policelli, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies